(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CANCERDETECT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CANCERDETECT

ST13

US500000097173919

Class

5, 10, 44

Filing

97173919

Registration

7281238

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

04/13/2025

Trademark type

Word

Nice classes

5, 10, 44

Filing date

12/15/2021

Registration date

01/16/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/16/2024

Last transaction

04/13/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

08/04/2022

First use in commerce

08/04/2022

Drawing code

4

Owner type

03

Owner location

Bellevue, WA

Examiner

TAYLOR, SLOAN

Law office

O20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Viome Life Sciences, Inc.

Representatives

Adam D. Matherly Holland & Knight LLP

Technical classification

Nice Classes

Class 5Class 10Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectioncancer and pre-malignant conditions

Class 10

Diagnostic apparatus for the detection of cancer; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for testing bodily fluidsa saliva collection kit comprised primarily of a saliva collection devicelaboratory assay for medical diagnosis of bodily fluidsrecorded electronic medical reports sold as a unit

Class 44

Medical servicesclinical testing services in the field of cancer and pre-malignant condition detection and/or diagnosis; Medical testing for diagnostic or treatment purposes in the field of cancer and pre-malignant condition detection

Publications

History of USPTO decisions and trademark events.

29 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/08/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/08/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/08/2025

NRCS

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/22/2024

NRCS

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/16/2024

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

01/16/2024

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

08/03/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

08/01/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/01/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

08/01/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/01/2023

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

07/21/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

07/20/2023

GNFR

FINAL REFUSAL E-MAILED

07/20/2023

CNFR

FINAL REFUSAL WRITTEN

07/20/2023

IUAA

USE AMENDMENT ACCEPTED

07/20/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/20/2023

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

03/18/2023

IUAF

USE AMENDMENT FILED

03/18/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/17/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/17/2023

EAAU

TEAS AMENDMENT OF USE RECEIVED

03/17/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/20/2022

GNRT

NON-FINAL ACTION E-MAILED

09/20/2022

CNRT

NON-FINAL ACTION WRITTEN

09/20/2022

DOCK

ASSIGNED TO EXAMINER

09/19/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

07/20/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/20/2021

NWAP

NEW APPLICATION ENTERED

12/18/2021

Continuous trademark protection

Get notified about every new filing that threatens CANCERDETECT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.